Dainippon Sumitomo Pharma Kicks off Operations.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Oct 3, 2005 - (JCNN JCNN Japan Corporate News Network ) - Dainippon Sumitomo Pharma, a merged company of Dainippon Pharmaceutical and Sumitomo Pharmaceuticals, has launched its full-scale operations on October 1. The new company, which is headquartered in Osaka, has a capital of 22.4 billion yen and 5,150 employees on a non-consolidated base. In a medium- and long-perspective, it aims to consolidate its presence in the field of diabetes and central nervous system disorders Nervous system disorders A satisfactory classification of diseases of the nervous system should include not only the type of reaction (congenital malformation, infection, trauma, neoplasm, vascular diseases, and degenerative, metabolic, toxic, or deficiency . The new company is the fifth-largest pharmaceutical company in Japan. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion